134 related articles for article (PubMed ID: 20649872)
1. Economic evaluation in clinical nephrology: part 2. Applying economic evaluations in clinical nephrology.
Wong G; Howard K; Craig JC
Nephrology (Carlton); 2010 Aug; 15(5):533-9. PubMed ID: 20649872
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation in clinical nephrology: Part 1. An introduction to conducting an economic evaluation in clinical practice.
Wong G; Howard K; Craig JC
Nephrology (Carlton); 2010 Jun; 15(4):434-40. PubMed ID: 20609095
[TBL] [Abstract][Full Text] [Related]
3. Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology.
Drummond M; Evans B; LeLorier J; Karakiewicz P; Martin D; Tugwell P; MacLeod S
Can J Clin Pharmacol; 2009; 16(2):e273-81; discussion e282-4. PubMed ID: 19439771
[TBL] [Abstract][Full Text] [Related]
4. Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.
Cosler LE; Lyman GH
Cancer Invest; 2009 Dec; 27(10):953-9. PubMed ID: 19909009
[No Abstract] [Full Text] [Related]
5. [Cancer of the kidney in adults. Economic aspects].
Prog Urol; 1997 Nov; 7(5):901-4. PubMed ID: 9458486
[No Abstract] [Full Text] [Related]
6. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
7. [Medical-economic evaluation of lung cancers. Theoretical approaches and practical applications].
Vergnenegre A; Chouaïd C; Lafuma A
Rev Mal Respir; 1998 Sep; 15(4):469-78. PubMed ID: 9805757
[TBL] [Abstract][Full Text] [Related]
8. Cost, effectiveness, and cost-effectiveness.
Diamond GA; Kaul S
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):49-54. PubMed ID: 20031812
[No Abstract] [Full Text] [Related]
9. The limits of cost-effectiveness analysis.
Weintraub WS; Cohen DJ
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):55-8. PubMed ID: 20031813
[No Abstract] [Full Text] [Related]
10. Critical appraisal of published economic evaluations of home care for the elderly.
Ramos ML; Ferraz MB; Sesso R
Arch Gerontol Geriatr; 2004; 39(3):255-67. PubMed ID: 15381344
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
Lyman GH
Cancer Invest; 2009 Jul; 27(6):593-7. PubMed ID: 19557579
[No Abstract] [Full Text] [Related]
12. Economic evaluation of cancer therapies: more and better studies will lead to better choices in cancer care.
Uyl-de Groot CA
Eur J Cancer; 2006 Nov; 42(17):2862-6. PubMed ID: 17008095
[TBL] [Abstract][Full Text] [Related]
13. How to read critically a prognostic cohort study.
Palmer SC; Strippoli GF
Nephrology (Carlton); 2010 Oct; 15(7):676-82. PubMed ID: 21040162
[TBL] [Abstract][Full Text] [Related]
14. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
[No Abstract] [Full Text] [Related]
15. Modelling in the economic evaluation of health care: selecting the appropriate approach.
Barton P; Bryan S; Robinson S
J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
[TBL] [Abstract][Full Text] [Related]
16. [German recommendations for health care economic evaluation studies. Revised version of the Hannover consensus. Hannover Consensus Group].
Med Klin (Munich); 2000 Jan; 95(1):52-5. PubMed ID: 10668346
[TBL] [Abstract][Full Text] [Related]
17. [Parameter of evidence-based medicine in health care economics].
Wasem J; Siebert U
Z Arztl Fortbild Qualitatssich; 1999 Aug; 93(6):427-36. PubMed ID: 10519192
[TBL] [Abstract][Full Text] [Related]
18. Systematic reviews of economic evaluations: utility or futility?
Anderson R
Health Econ; 2010 Mar; 19(3):350-64. PubMed ID: 19378354
[TBL] [Abstract][Full Text] [Related]
19. Using economic evidence in clinical practice.
Stone PW
J Med Pract Manage; 2002; 17(5):272-7. PubMed ID: 12024866
[TBL] [Abstract][Full Text] [Related]
20. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
